`
`THIS FIFTH LUCENTIS DEVELOPMENT AGREEME T A ENDM F: T (''Amendment"),
`for one Lucentis SD Placebo GMP Batch , is entered into by and between Novartis Pharma AG, a
`company duly organized and existing under the laws of Switzerland, having its rinci al
`lace of
`business at Lichtstrasse 35, CH-4065 Basel , Switzerland ("NOVARTIS'.), and
`
`-1-
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(US)00006196
`
`Novartis Exhibit 2158.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.002
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.003
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.004
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.005
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.006
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.006
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.007
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.007
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.008
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.008
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.009
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.009
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0010
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0010
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0011
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0011
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0012
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0012
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0013
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0013
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0014
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0014
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0015
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0015
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0016
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0016
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`
`
`Novartis Exhibit 2158.0017
`Regeneron v. Novartis, IPR202 1-008 16
`
`Novartis Exhibit 2158.0017
`Regeneron v. Novartis, IPR2021-00816
`
`